Primary Prevention of Gestational Diabetes Mellitus and Large-for-Gestational-Age Newborns by Lifestyle Counseling: A Cluster-Randomized Controlled Trial
Background:
Our objective was to examine whether gestational diabetes mellitus (GDM) or newborns' high birthweight can be prevented by lifestyle counseling in pregnant women at high risk of GDM.
Method and Findings:
We conducted a cluster-randomized trial, the NELLI study, in 14 municipalities in Finland, where 2,271 women were screened by oral glucose tolerance test (OGTT) at 8–12 wk gestation. Euglycemic (n = 399) women with at least one GDM risk factor (body mass index [BMI] ≥25 kg/m2, glucose intolerance or newborn's macrosomia (≥4,500 g) in any earlier pregnancy, family history of diabetes, age ≥40 y) were included. The intervention included individual intensified counseling on physical activity and diet and weight gain at five antenatal visits. Primary outcomes were incidence of GDM as assessed by OGTT (maternal outcome) and newborns' birthweight adjusted for gestational age (neonatal outcome). Secondary outcomes were maternal weight gain and the need for insulin treatment during pregnancy. Adherence to the intervention was evaluated on the basis of changes in physical activity (weekly metabolic equivalent task (MET) minutes) and diet (intake of total fat, saturated and polyunsaturated fatty acids, saccharose, and fiber). Multilevel analyses took into account cluster, maternity clinic, and nurse level influences in addition to age, education, parity, and prepregnancy BMI. 15.8% (34/216) of women in the intervention group and 12.4% (22/179) in the usual care group developed GDM (absolute effect size 1.36, 95% confidence interval [CI] 0.71–2.62, p = 0.36). Neonatal birthweight was lower in the intervention than in the usual care group (absolute effect size −133 g, 95% CI −231 to −35, p = 0.008) as was proportion of large-for-gestational-age (LGA) newborns (26/216, 12.1% versus 34/179, 19.7%, p = 0.042). Women in the intervention group increased their intake of dietary fiber (adjusted coefficient 1.83, 95% CI 0.30–3.25, p = 0.023) and polyunsaturated fatty acids (adjusted coefficient 0.37, 95% CI 0.16–0.57, p<0.001), decreased their intake of saturated fatty acids (adjusted coefficient −0.63, 95% CI −1.12 to −0.15, p = 0.01) and intake of saccharose (adjusted coefficient −0.83, 95% CI −1.55 to −0.11, p = 0.023), and had a tendency to a smaller decrease in MET minutes/week for at least moderate intensity activity (adjusted coefficient 91, 95% CI −37 to 219, p = 0.17) than women in the usual care group. In subgroup analysis, adherent women in the intervention group (n = 55/229) had decreased risk of GDM (27.3% versus 33.0%, p = 0.43) and LGA newborns (7.3% versus 19.5%, p = 0.03) compared to women in the usual care group.
Conclusions:
The intervention was effective in controlling birthweight of the newborns, but failed to have an effect on maternal GDM.
Trial registration:
Current Controlled Trials ISRCTN33885819
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Primary Prevention of Gestational Diabetes Mellitus and Large-for-Gestational-Age Newborns by Lifestyle Counseling: A Cluster-Randomized Controlled Trial. PLoS Med 8(5): e32767. doi:10.1371/journal.pmed.1001036
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001036
Souhrn
Background:
Our objective was to examine whether gestational diabetes mellitus (GDM) or newborns' high birthweight can be prevented by lifestyle counseling in pregnant women at high risk of GDM.
Method and Findings:
We conducted a cluster-randomized trial, the NELLI study, in 14 municipalities in Finland, where 2,271 women were screened by oral glucose tolerance test (OGTT) at 8–12 wk gestation. Euglycemic (n = 399) women with at least one GDM risk factor (body mass index [BMI] ≥25 kg/m2, glucose intolerance or newborn's macrosomia (≥4,500 g) in any earlier pregnancy, family history of diabetes, age ≥40 y) were included. The intervention included individual intensified counseling on physical activity and diet and weight gain at five antenatal visits. Primary outcomes were incidence of GDM as assessed by OGTT (maternal outcome) and newborns' birthweight adjusted for gestational age (neonatal outcome). Secondary outcomes were maternal weight gain and the need for insulin treatment during pregnancy. Adherence to the intervention was evaluated on the basis of changes in physical activity (weekly metabolic equivalent task (MET) minutes) and diet (intake of total fat, saturated and polyunsaturated fatty acids, saccharose, and fiber). Multilevel analyses took into account cluster, maternity clinic, and nurse level influences in addition to age, education, parity, and prepregnancy BMI. 15.8% (34/216) of women in the intervention group and 12.4% (22/179) in the usual care group developed GDM (absolute effect size 1.36, 95% confidence interval [CI] 0.71–2.62, p = 0.36). Neonatal birthweight was lower in the intervention than in the usual care group (absolute effect size −133 g, 95% CI −231 to −35, p = 0.008) as was proportion of large-for-gestational-age (LGA) newborns (26/216, 12.1% versus 34/179, 19.7%, p = 0.042). Women in the intervention group increased their intake of dietary fiber (adjusted coefficient 1.83, 95% CI 0.30–3.25, p = 0.023) and polyunsaturated fatty acids (adjusted coefficient 0.37, 95% CI 0.16–0.57, p<0.001), decreased their intake of saturated fatty acids (adjusted coefficient −0.63, 95% CI −1.12 to −0.15, p = 0.01) and intake of saccharose (adjusted coefficient −0.83, 95% CI −1.55 to −0.11, p = 0.023), and had a tendency to a smaller decrease in MET minutes/week for at least moderate intensity activity (adjusted coefficient 91, 95% CI −37 to 219, p = 0.17) than women in the usual care group. In subgroup analysis, adherent women in the intervention group (n = 55/229) had decreased risk of GDM (27.3% versus 33.0%, p = 0.43) and LGA newborns (7.3% versus 19.5%, p = 0.03) compared to women in the usual care group.
Conclusions:
The intervention was effective in controlling birthweight of the newborns, but failed to have an effect on maternal GDM.
Trial registration:
Current Controlled Trials ISRCTN33885819
: Please see later in the article for the Editors' Summary
Zdroje
1. 2010 Diagnosis and classification of diabetes mellitus. Diabetes Care 33 S62 S69
2. FerraraA 2007 Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30 S141 S146
3. MetzgerBELoweLPDyerARTrimbleERChaovarindrU 2008 Hyperglycemia and adverse pregnancy outcomes. New Engl J Med 358 1991 2002
4. JuHRumboldARWillsonKJCrowtherCA 2008 Borderline gestational diabetes mellitus and pregnancy outcomes. BMC Pregnancy and Childbirth 8 31
5. ClausenTDMathiesenERHansenTPedersenOJensenDM 2009 Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin End Metab 94 2464 2470
6. BoSMenatoGLezoASignorileABardelliC 2001 Dietary fat and gestational hyperglycaemia. Diabetologia 44 972 978
7. HeddersonMMGundersonEPFerraraA 2010 Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol 115 597 604
8. Morisset A-S, St-YvesAVeilletteJWeisnagelSJTchernofA 2010 Prevention of gestational diabetes mellitus: a review of studies on weight management. Diabetes Metab Res Rev 26 17 25
9. SaldanaTMSiega-RizAMAdairLS 2004 Effect of macronutrient intake on the development of glucose intolerance during pregnancy. Am J Clin Nutr 79 479 486
10. WangYStorlienLHJenkinsABTapsellLCJinY 2000 Dietary variables and glucose tolerance in pregnancy. Diabetes Care 23 460 464
11. TobiasDKZhangCvan DamRMBowersKHuFB 2011 Physical activity before and during pregnancy and risk of gestational diabetes mellitus: a meta-analysis. Diabetes Care 34 223 229
12. 2006 Impact of physical activity during pregnancy and postpartum on chronic disease risk. Med Sci Sports Exerc 38 989 1006
13. StreulingIBeyerleinAvon KriesR 2010 Can gestational weight gain be modified by increasing physical activity and diet counselling? A meta-analysis of interventional trials. Am J Clin Nutr 92 678 687
14. HopkinsSABaldiJCCutfieldWSMcCowanLHofmanPL 2010 Exercise training in pregnancy reduces offspring size without changes in maternal insulin sensitivity. J Clin Endocr Metab 95 2080 2088
15. KinnunenTIPasanenMAittasaloMFogelholmMHilakivi-ClarkeL 2007 Preventing excessive weight gain during pregnancy - a controlled trial in primary health care. Eur J Clin Nutr 61 884 891
16. AittasaloMPasanenMFogelholmMKinnunenTIOjalaK 2008 Physical activity counseling in maternity and child health care - a controlled trial. BMC Women's Health 8 14
17. LuotoRKinnunenTIAittasaloMOjalaKMansikkamäkiK 2010 Prevention of gestational diabetes: design of a cluster-randomised controlled trial and one year- follow-up. BMC Pregnancy and Childbirth 10 39
18. Institute of Medicine 1990 Nutrition during pregnancy. Weight gain and nutrient supplements. Report of the Subcommittee on Nutritional Status and Weight Gain during Pregnancy. Subcommittee on Dietary Intake and Nutrient Supplements during Pregnancy. Committee on Nutritional Status during Pregnancy and Lactation. Food and Nutrition Board Washington (D.C.) National Academy Press
19. ArtalRO'TooleM 2003 Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period. Br J Sports Med 37 6 12
20. HaskellWLLeeIMPateRRPowellKEBlairSN 2007 Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 116 1081 93
21. AittasaloMPasanenMFogelholmMOjalaK 2010 Validity and repeatability of a short pregnancy leisure time physical activity questionnaire. J Phys Act Health 7 109 118
22. Valtion ravitsemusneuvottelukunta. [Finnish dietary recommendations at 2005] Suomalaiset ravitsemussuositukset 2005 – ravinto ja liikunta tasapainoon (in Finnish) Helsinki Edita
23. TuomilehtoJLindstromJErikssonJGValleTTHamalainenH 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med 344 1343 1350
24. ErkkolaMKarppinenMJavanainenJRasanenLKnipM 2001 Validity and reproducibility of a food frequency questionnaire for pregnant Finnish women. Am J Epidemiol 154 466 476
25. WallaceTMLevyJCMatthewsDR 2004 Use and abuse of HOMA modeling. Diab Care 27 1487 1495
26. KramerMSPlattRWWenSWJosephKSAllenA 2001 A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108 E35
27. ACOG Committee opinion 2002 Number 267. January 2002: exercise during pregnancy and the postpartum period. Obstet Gynecol 99 171 173
28. HorvathKKochKJeitlerKMatyasEBenderR 2010 Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. Br Med J 340 c1395
29. LandonMBSpongCYThomECarpenterMWRaminSM 2009 A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361 1339 1348
30. CrowtherCAHillerJEMossJRMcPheeAJJeffriesWS 2005 Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352 2477 2486
31. TieuJCrowtherCAMiddletonP 2009 Dietary advice in pregnancy for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews; 3 doi:10.1002/14651858.CD006674.pub2
32. OostdamNvan PoppelMNEekhoffEMWoutersMGvan MechelenW 2009 Design of FitFor2 study: the effects of an exercise program on insulin sensitivity and plasma glucose levels in pregnant women at high risk for gestational diabetes. BMC Pregnancy and Childbirth 9 1
33. Chasan-TaberLMarcusBHStanedECiccoloJTMarquezDX 2009 A randomized controlled trial of prenatal physical activity to prevent gestational diabetes: design and methods. J Women's Health 18 851 859
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 5
- Statinová intolerance
- Jak rozpoznat pacienty s familiární hypercholesterolémií ve své praxi
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Myasthenia gravis: kombinace chirurgie a farmakoterapie jako nejefektivnější modalita?
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial
- Effectiveness of Early Antiretroviral Therapy Initiation to Improve Survival among HIV-Infected Adults with Tuberculosis: A Retrospective Cohort Study
- Primary Prevention of Gestational Diabetes Mellitus and Large-for-Gestational-Age Newborns by Lifestyle Counseling: A Cluster-Randomized Controlled Trial
- Meta-analyses of Adverse Effects Data Derived from Randomised Controlled Trials as Compared to Observational Studies: Methodological Overview